Transactions
Showing 271-285 of 930 items
-
N/a
Cansortium
Financial Advisor (restructuring and consent consolidation)
-
Level Ex
Financial Advisor (Sell side)
-
US$48m
TELA Bio
Lead Manager (Follow-On)
-
US$74m
Castle Biosciences, Inc.
Passive Bookrunner (Follow-On)
-
Undisclosed Client
N/a
Undisclosed Client
A fast growing digital media business focused on the broader consumer health space has received a significant investment from Abry Partners
-
US$29m
KORU Medical Systems
Joint Bookrunner (Follow-on Offering)
-
US$256m
Genetron Holdings Limited
Co-Manager (IPO)
-
US$78m
Shockwave Medical, Inc.
Financial Advisor (Follow-On)
-
OneCare Media
Financial Advisor to OneCare Media on its Significant Investment from Abry Partners
-
US$347m
ChemoCentryx, Inc
Passive Bookrunner (CMPO)
-
N/a
Cormis Partners
Financial Adviser (Sell side)
-
US$18m
Sundial Growers, Inc.
Joint Agent (Private Placement)
-
US$633m
Allogene Therapeutics, Inc.
Co-Manager (Follow-On)
-
US$550m
Livongo Health, Inc.
Co-Manager (144a Convert)
-
US$36m
Kaleido Biosciences, Inc.
Lead Manager (CMPO)